Chemoprevention of Cancer of the Upper Respiratory Tract of the Syrian Golden Hamster by Aerosol Administration of Difluoromethylornithine and 5-Fluorouracil

Cancer Research

Volumn 64, Issue 7, 2004, Pages 2347-2349

  Wattenberg, Lee W ^a,c   Wiedmann, Timothy S ^b   Estensen, Richard D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; FLUOROURACIL; METHYLNITROSOUREA; ORNITHINE DECARBOXYLASE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPERIMENTAL MODEL; HAMSTER; HIGH RISK POPULATION; LUNG CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; RISK BENEFIT ANALYSIS; SQUAMOUS CELL CARCINOMA; UPPER RESPIRATORY TRACT CANCER;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CRICETINAE; DISEASE MODELS, ANIMAL; EFLORNITHINE; FLUOROURACIL; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; MESOCRICETUS; METHYLNITROSOUREA; PHARYNGEAL NEOPLASMS;

EID: 1942538547     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-4032     Document Type: Article

References (19)

1. Wattenberg LW, Wiedmann TS, Estensen RD, et al. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myoinositol. Carcinogenesis 2000;21:179-82.
2. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1997;57:5489-92.
3. Dahl AR, Grossi IM, Houchens DP, et al. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low does: a pilot study. Clin Cancer Res 2000;6:3015-24.
4. Tatsumura T, Koyama S, Tsujimoto M, Kitagawa M, Kagamimon S. Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br J Cancer 1993;68:1146-9.
5. Sharma S, White D, Imondi AR, Placke ME, Vail DM. Kris MG. Development of inhalational agents for oncologic use. J Clin Oncol 2001;19:1839-47.
6. Meyskens FL Jr, Gerner EW. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999;5:945-51.
7. Auvinen M, Paasinen A, Andersson LC, Hölttä E. Ornithine decarboxylase activity is critical for cell transformation Nature (Lond) 1992;360:355-8.
8. Tanaka T, Kojima T, Hara A, Sawada H, Mori H. Chemoprevention of oral carcinogenesis by DL-α-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline-1-oxide-induced tongue neoplasms in rats. Cancer Res 1993;53:772-6.
9. Fischer SM, Lee M, Lubet RA. Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice. Carcinogenesis 2001;22:83-8.
10. Ratko TA, Detrisac CJ, Rao KVN, Thomas CF, Kelloff GJ, Moon RC. Interspecies analysis of the chemopreventive efficacy of dietary α-difluoromethylornithine. Anticancer Res 1990;10:67-72.
11. Alberts DS, Dorr RT, Einspahr JG, et al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol Biomark Prev 2000;9:1281-6.
12. Meyskens FL, Gerner EW, Emerson S, et al. Effect of α -difluoromethylomithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst (Bethesda) 1998;90:1212-8.
13. Simoneau AR, Gerner EW, Phung M, McLaren CE, Meyskens FL Jr. α-Difluoromethylornithine and polyamine levels in the human prostate: results of a phase 11a trial. J Natl Cancer Inst (Bethesda) 2001;93:57-9.
14. Grem JL. Mechanisms of action and modulation of fluorouracil. Semin Radiat Oncol 1997;7:249-59.
15. Otake Y, Tanaka F, Yanagihara K, et al. Expression of thymidylate synthase in human non-small cell lung cancer. Jpn J Cancer Res 1999;90:1248-53.
16. Moon RC, Rao KVN, Detrisac CJ, Kelloff GJ. Hamster lung cancer model of carcinogenesis and chemoprevention. Adv Exp Med Biol 1992;320:55-61.
17. Le C. Introductory biostatistics. Hoboken, NJ: John Wiley & Sons, 2003. Section 6.7, p. 230-3.
18. Williams AC, Klein E. Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer (Phila) 1970;25:450-62.
19. Olson PR, Wattenberg LW. Inhibition by 5-fluorouracil of the early stages of chemical carcinogenesis in mouse skin (34054). Proc Soc Exp Biol Med 1969;131:1135-7.